📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-10 17:39
161 analysed today
FollowTelegram
161
Today
149,562
All-time analysed
42,894
Positive
6,654
Negative
91,341
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
JFL Life Sciences Q1 Net Profit Grows 49% YoY to ₹1.11 Cr; Revenue Dips 4% to ₹11.10 Cr
JFL Life Sciences reported a 49.3% YoY increase in Net Profit to ₹1.11 Cr for Q1 FY27, up from ₹0.75 Cr in Q1 FY26. This profit growth was achieved despite a 4.2% decline in Revenue from Operations, which stood at ₹11.10 Cr. The results highlight significant sequential volatility, as revenue dropped 82.4% from the outlier ₹63.05 Cr reported in Q4 FY26. The company managed to reduce total expenses by 5.2% YoY, which supported the bottom-line growth.
Confidence: HIGH
What changedThe company released its unaudited financial results for the first quarter of the 2026-27 fiscal year, showing improved profitability on a lower revenue base.
Why it mattersFor a small-cap company (₹91 Cr market cap), maintaining profitability during revenue dips is positive, but the extreme quarterly revenue fluctuations (₹11 Cr vs ₹63 Cr) indicate high business unpredictability.
Revenue (Q1 FY27): ₹11.10 CrNet Profit (Q1 FY27): ₹1.11 CrQoQ Revenue Change: -82.4%YoY Profit Growth: 49.3%Q1 Revenue vs TTM Revenue: 8.5%
📅 Short termThe stock may see neutral to slightly cautious sentiment as the market digests the sharp sequential revenue decline despite the YoY profit growth.
📈 Long termThe company needs to demonstrate consistent revenue scaling and address its high working capital intensity to achieve a structural re-rating.
⚠ Risk flags
- Extreme quarterly revenue volatility
- High working capital intensity (Inventory and Receivables were 81.5% of assets in FY26)
- Regional concentration with 100% manufacturing in Gujarat
Key Highlights
Net Profit increased to ₹1.11 Cr from ₹0.75 Cr in the same quarter last year, a growth of 49.3%.
Revenue from Operations stood at ₹11.10 Cr, a slight decline from ₹11.59 Cr in Q1 FY26.
Total Expenses decreased to ₹9.63 Cr from ₹10.16 Cr YoY, primarily due to lower material costs.
Earnings Per Share (EPS) improved to ₹0.34 from ₹0.23 in the year-ago period.
Profit Before Tax (PBT) margin improved slightly to 13.4% compared to 12.3% in Q1 FY26.
👀 What to Watch
Investors should monitor the company's ability to stabilize its quarterly revenue, as the sharp drop from Q4 FY26 suggests highly lumpy order execution or seasonal factors.
